The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
Open accessAbstract
Serum samples from patients with meningococcal disease were examined for the presence of IL-6, TNF-alpha, and LPS. Median serum concentration of IL-6 was 1,000 times higher in patients with septic shock (189 ng/ml) than in patients with bacteriaemia, meningitis, or combined septic shock and meningitis. 11 of 21 patients with serum levels greater than 3.0 ng/ml died, whereas all 58 patients with serum levels at less than or equal to 3.0 ng/ml, survived. All four patients with serum IL-6 levels greater than 750 ng/ml, died. IL-1 was detected in serum from three patients who also had high serum levels of IL-6, TNF-alpha, and LPS, and rapidly fatal courses. IL-6 appeared to be released into serum later than TNF-alpha, and was detected in serum for up to 36 h. The half-life of IL-6 and TNF-alpha was calculated to be 103 +/- 27 min and 70 +/- 11 min, respectively. These data indicate that a complex pattern of cytokines exists in serum from patients with meningococcal septic shock, and that the release of IL-6 and IL-1, in addition to TNF-alpha, is associated with fatal outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
Le, J., & Vilček, J. (1987) · PubMed · Cited by 1,327
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,243
Self-citationWaage, A., Halstensen, A., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,096
Self-citationProduction of hybridoma growth factor by human monocytes
Aarden, L. A., De Groot, E. R., Schaap, O. L., & Lansdorp, P. M. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171004 · Cited by 1,092
Brandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A., Bruun, J. N., Halvorsen, S., & Sorensen, E. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.2.195 · Cited by 553
Self-citationMultiple actions of interleukin 6 within a cytokine network
Wong, G. G., & Clark, S. C. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91200-5 · Cited by 529
The role of cachectin/TNF in endotoxic shock and cachexia
Ceramil, A., & Beutler, B. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91353-9 · Cited by 328
Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.
van Oers, M. H. J., Heyden, A., & Aarden, L. A. (1988) · PubMed · Cited by 267
Cited by
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Multiple Organ Failure Pathophysiology and Potential Future Therapy
DEITCH, E. A. (1992) · Annals of Surgery · doi:10.1097/00000658-199208000-00002 · Cited by 1,380
Miura, M. (1993) · Cell · doi:10.1016/0092-8674(93)90486-a · Cited by 1,373
Bone, R. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-457 · Cited by 1,368
Sampaio, E. P., Sarno, E. N., Galilly, R., Cohn, Z. A., & Kaplan, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.699 · Cited by 1,192
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040
Inflammatory response to cardiopulmonary bypass
Butler, J., Rocker, G. M., & Westaby, S. (1993) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(93)91048-r · Cited by 1,033
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978
Self-citationSerum Cytokine Levels in Human Septic Shock
Pinsky, M. R., Vincent, J.-L., Deviere, J., Alegre, M., Kahn, R. J., & Dupont, E. (1993) · Chest · doi:10.1378/chest.103.2.565 · Cited by 884
Increased plasma levels of interleukin-6 in sepsis [see comments]
Hack, C., De Groot, E., Felt-Bersma, R., Nuijens, J., Strack Van Schijndel, R., Eerenberg-Belmer, A., Thijs, L., & Aarden, L. (1989) · Blood · doi:10.1182/blood.v74.5.1704.1704 · Cited by 811
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
DAMA, P., LEDOUX, D., NYS, M., VRINDTS, Y., GROOTE, D. D., FRANCHIMONT, P., & LAMY, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808
Kumar, A., Thota, V, Dee, L., Olson, J., Uretz, E., & Parrillo, J. E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.949 · Cited by 791
Persistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS
Meduri, G. U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Umberger, R., & Leeper, K. (1995) · Chest · doi:10.1378/chest.107.4.1062 · Cited by 789
Sedger, L. M., & McDermott, M. F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.016 · Cited by 771
Dysregulation of in vitro cytokine production by monocytes during sepsis.
Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J. P., & Cavaillon, J. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115493 · Cited by 754
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 745
Infectious diseases associated with complement deficiencies
Figueroa, J. E., & Densen, P. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.3.359 · Cited by 729
Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm
Tanaka, T., Narazaki, M., & Kishimoto, T. (2016) · Immunotherapy · doi:10.2217/imt-2016-0020 · Cited by 708
Inflammatory Cytokines in the BAL of Patients With ARDS
Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., & Postlethwaite, A. (1995) · Chest · doi:10.1378/chest.108.5.1303 · Cited by 695
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Interleukin-6: designing specific therapeutics for a complex cytokine
Garbers, C., Heink, S., Korn, T., & Rose-John, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.45 · Cited by 643
Fong, Y., Tracey, K. J., Moldawer, L. L., Hesse, D. G., Manogue, K. B., Kenney, J. S., Lee, A. T., Kuo, G. C., Allison, A. C., & Lowry, S. F. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1627 · Cited by 641
Characterization of the Inflammatory Response to Severe COVID-19 Illness
McElvaney, O. J., McEvoy, N. L., McElvaney, O. F., Carroll, T. P., Murphy, M. P., Dunlea, D. M., Ní Choileáin, O., Clarke, J., O’Connor, E., Hogan, G., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-1583oc · Cited by 628
Interleukin-6 and its receptors: a highly regulated and dynamic system
Wolf, J., Rose-John, S., & Garbers, C. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.024 · Cited by 618
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199601000-00026 · Cited by 603
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144 · Cited by 588
Self-citationMiethke, T., Wahl, C., Heeg, K., Echtenacher, B., Krammer, P. H., & Wagner, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.91 · Cited by 574
Stuber, F., Petersen, M., Bokelmann, F., & Schade, U. (1996) · Critical Care Medicine · doi:10.1097/00003246-199603000-00004 · Cited by 551
Calandra, T., Baumgartner, J.-D., Grau, G. E., Wu, M.-M., Lambert, P.-H., Schellekens, J., Verhoef, J., Glauser, M. P., & Swiss-Dutch J5 Immunoglobulin Study Group (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.5.982 · Cited by 547
Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
Faquin, W., Schneider, T., & Goldberg, M. (1992) · Blood · doi:10.1182/blood.v79.8.1987.1987 · Cited by 532
Targeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., & Fujiwara, H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1529 · Cited by 517
Interleukin-6: Biology, signaling and strategies of blockade
Schaper, F., & Rose-John, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.004 · Cited by 509
The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients
Fingerle, G., Pforte, A., Passlick, B., Blumenstein, M., Strobel, M., & Ziegler- Heitbrock, H. (1993) · Blood · doi:10.1182/blood.v82.10.3170.3170 · Cited by 497
Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity
Husebye, H., Halaas, Ø., Stenmark, H., Tunheim, G., Sandanger, Ø., Bogen, B., Brech, A., Latz, E., & Espevik, T. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600991 · Cited by 486
Self-citationLe, J., & Vilček, J. (1990) · Pathology Reviews • 1990 · doi:10.1007/978-1-4612-0485-5_7 · Cited by 474
Systemic inflammatory response syndrome
Davies, M. G., & Hagen, P.-O. (1997) · Journal of British Surgery · doi:10.1002/bjs.1800840707 · Cited by 456
Waage, A., Halstensen, A., Shalaby, R., Brandtzaeg, P., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.1859 · Cited by 454
Self-citationSepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
Iskander, K. N., Osuchowski, M. F., Stearns-Kurosawa, D. J., Kurosawa, S., Stepien, D., Valentine, C., & Remick, D. G. (2013) · Physiological Reviews · doi:10.1152/physrev.00037.2012 · Cited by 453
Martich, G. D., Danner, R. L., Ceska, M., & Suffredini, A. F. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.4.1021 · Cited by 444
Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis
Natanson, C., Hoffman, W. D., Suffredini, A. F., Eichacker, P. Q., & Danner, R. L. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00009 · Cited by 442
Calandra, T., Gerain, J., Heumann, D., Baumgartner, J.-D., & Glauser, M. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90069-a · Cited by 442
A safe and potent anti-CD19 CAR T cell therapy
Ying, Z., Huang, X. F., Xiang, X., Liu, Y., Kang, X., Song, Y., Guo, X., Liu, H., Ding, N., Zhang, T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0421-7 · Cited by 441
Six at Six: Interleukin-6 Measured 6 H After the Initiation of Sepsis Predicts Mortality Over 3 Days
Remick, D. G., Bolgos, G. R., Siddiqui, J., Shin, J., & Nemzek, J. A. (2002) · Shock · doi:10.1097/00024382-200206000-00004 · Cited by 436
The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
Garbers, C., Aparicio-Siegmund, S., & Rose-John, S. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.008 · Cited by 429
Camargo, C. A., Madden, J. F., Gao, W., Selvan, R. S., & Clavien, P. (1997) · Hepatology · doi:10.1002/hep.510260619 · Cited by 421
Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function
Cain, B. S., Meldrum, D. R., Dinarello, C. A., Meng, X., Joo, K. S., Banerjee, A., & Harken, A. H. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00018 · Cited by 421
Role of Monocytes in Atherogenesis
ØSTERUD, B., & BJØRKLID, E. (2003) · Physiological Reviews · doi:10.1152/physrev.00005.2003 · Cited by 412
Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy
Ram, S., Lewis, L. A., & Rice, P. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-09 · Cited by 405
van der Poll, T., Levi, M., Hack, C. E., ten Cate, H., van Deventer, S. J., Eerenberg, A. J., de Groot, E. R., Jansen, J., Gallati, H., & Büller, H. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1253 · Cited by 383
Functional and clinical aspects of the myelomonocyte protein calprotectin.
Johne, B., Fagerhol, M. K., Lyberg, T., Prydz, H., Brandtzaeg, P., Naess-Andresen, C. F., & Dale, I. (1997) · Molecular Pathology · doi:10.1136/mp.50.3.113 · Cited by 379
Self-citationInterleukin‐6: Structure‐function relationships
Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J. M., & Ward, L. D. (1997) · Protein Science · doi:10.1002/pro.5560060501 · Cited by 371
Reinhart, K., Wiegand-Lohnert, C., Grimminger, F., Kaul, M., Withington, S., Treacher, D., Eckart, J., Willatts, S., Bouza, C., Krausch, D., et al. (1996) · Critical Care Medicine · doi:10.1097/00003246-199605000-00003 · Cited by 361
Martin, C., Boisson, C., Haccoun, M., Thomachot, L., & Mege, J.-L. (1997) · Critical Care Medicine · doi:10.1097/00003246-199711000-00018 · Cited by 356
Leser, H.-G., Gross, V., Scheibenbogen, C., Heinisch, A., Salm, R., Lausen, M., Rückauer, K., Andreesen, R., Farthmann, E. H., & Schölmerich, J. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90539-w · Cited by 351
Interleukin 1: the first interleukin
di Giovine, F. S., & Duff, G. W. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90005-t · Cited by 338
The shedding protease ADAM17: Physiology and pathophysiology
Zunke, F., & Rose-John, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.07.001 · Cited by 336
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis
Maimone, D., Gregory, S., Arnason, B. G. W., & Reder, A. T. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90073-g · Cited by 333
Kern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331
“Thus, IL-6 regulates, amongst others, acute phase responses and liver regeneration, resulting in dramatically increased IL-6 serum levels upon states of infection, inflammation, and liver damage [98,110,117].”
BackgroundProtective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression
Riedemann, N. C., Neff, T. A., Guo, R.-F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., & Ward, P. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.503 · Cited by 330
Kang, S., Tanaka, T., Inoue, H., Ono, C., Hashimoto, S., Kioi, Y., Matsumoto, H., Matsuura, H., Matsubara, T., Shimizu, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010229117 · Cited by 330
Pneumococcal Disease during HIV Infection: Epidemiologic, Clinical, and Immunologic Perspectives
Janoff, E. N., Breiman, R. F., Daley, C. L., & Hopewell, P. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-314 · Cited by 323
Hermans, P. W., Hibberd, M. L., Booy, R., Daramola, O., Hazelzet, J. A., de Groot, R., & Levin, M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02220-5 · Cited by 323
INTERLEUKIN-6 STIMULATES ANTERIOR PITUITARY HORMONE RELEASE IN VITRO.
SPANGELO, B. L., JUDD, A. M., ISAKSON, P. C., & MACLEOD, R. M. (1989) · Endocrinology · doi:10.1210/endo-125-1-575 · Cited by 320
Jiang, Q., Akashi, S., Miyake, K., & Petty, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3541 · Cited by 320
Interleukin-8 in sepsis: relation to shock and inflammatory mediators
Hack, C. E., Hart, M., van Schijndel, R. J., Eerenberg, A. J., Nuijens, J. H., Thijs, L. G., & Aarden, L. A. (1992) · Infection and Immunity · doi:10.1128/iai.60.7.2835-2842.1992 · Cited by 319
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
Remy, K. E., Mazer, M., Striker, D. A., Ellebedy, A. H., Walton, A. H., Unsinger, J., Blood, T. M., Mudd, P. A., Yi, D. J., Mannion, D. A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140329 · Cited by 309
LEVI, M., VAN DER POLL, T., TEN CATE, H., & VAN DEVENTER, S. J. H. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.570614.x · Cited by 305
Cytokine Storm—Definition, Causes, and Implications
Jarczak, D., & Nierhaus, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911740 · Cited by 304
Hinson, R. M., Williams, J. A., & Shacter, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4885 · Cited by 302
Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo
Shalaby, M. R., Waage, A., Aarden, L., & Espevik, T. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90010-x · Cited by 294
Self-citationInterleukin 6 as an Energy Allocator in Muscle Tissue
Kistner, T. M., Pedersen, B. K., & Lieberman, D. E. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00538-4 · Cited by 295
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease
Gross, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293
Ng, P. C., Cheng, S. H., Chui, K. M., Fok, T. F., Wong, M. Y., Wong, W., Wong, R. P. O., & Cheung, K. L. (1997) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.77.3.f221 · Cited by 288
Interleukin-6: A candidate mediator of human prostate cancer morbidity
Twillie, D. A., Eisenberger, M. A., Carducci, M. A., Hseih, W.-S., Kim, W. Y., & Simons, J. W. (1995) · Urology · doi:10.1016/s0090-4295(99)80034-x · Cited by 286
Taming TNF: strategies to restrain this proinflammatory cytokine
Eigler, A., Sinha, B., Hartmann, G., & Endres, S. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01118-3 · Cited by 284
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Interleukin-6 Stimulates Coagulation, not Fibrinolysis, in Humans
Stouthard, J. M. L., Levi, M., Hack, C. E., Veenhof, C. H. N., Romijn, H. A., Sauerwein, H. P., & Poll, T. V. D. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650653 · Cited by 279
Pathogenesis and pathophysiology of bacterial meningitis
Tunkel, A. R., & Scheld, W. M. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.2.118 · Cited by 279
IL-1 Receptor-Associated Kinase Modulates Host Responsiveness to Endotoxin
Swantek, J. L., Tsen, M. F., Cobb, M. H., & Thomas, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4301 · Cited by 279
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
McElvaney, O. J., Curley, G. F., Rose-John, S., & McElvaney, N. G. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00103-x · Cited by 278
Soni, A., Pepper, G. M., Wyrwinski, P. M., Ramirez, N. E., Simon, R., Pina, T., Gruenspan, H., & Vaca, C. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80373-8 · Cited by 277
Shock and Multiple-Organ Dysfunction after Self-Administration of Salmonella Endotoxin
da Silva, A. M. T., Kaulbach, H. C., Chuidian, F. S., Lambert, D. R., Suffredini, A. F., & Danner, R. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282005 · Cited by 276
Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H., & Rose-John, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Martich, G. D., Boujoukos, A. J., & Suffredini, A. F. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80353-0 · Cited by 275
Cytokine signaling-regulation of the immune response in normal and critically ill states
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004001-00002 · Cited by 267
Cytokines and Metabolic Dysfunction After Severe Head Injury
OTT, L., McCLAIN, C. J., GILLESPIE, M., & YOUNG, B. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.447 · Cited by 266
Early treatment with parenteral penicillin in meningococcal disease.
Cartwright, K., Reilly, S., White, D., & Stuart, J. (1992) · BMJ · doi:10.1136/bmj.305.6846.143 · Cited by 265
OXPENTIFYLLINE IN ENDOTOXAEMIA
ZABEL, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92929-2 · Cited by 259
Role of the neutrophil in adult respiratory distress syndrome
Windsor, A. C. J., Mullen, P. G., Fowler, A. A., & Sugerman, H. J. (1993) · Journal of British Surgery · doi:10.1002/bjs.1800800106 · Cited by 259
Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis
Castellheim, A., Brekke, O. ‐., Espevik, T., Harboe, M., & Mollnes, T. E. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02255.x · Cited by 257
Self-citationModulation of Inflammation and Cytokine Production by Dietary (n-3) Fatty Acids
Blok, W. L., Katan, M. B., & van der Meer, J. W. M. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.6.1515 · Cited by 255
DI CESARE, P. E., CHANG, E., PRESTON, C. F., & LIU, C.-J. (2005) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200509000-00003 · Cited by 255
Sepsis and serum cytokine concentrations
Damas, P., Canivet, J.-L., De Groote, D., Vrindts, Y., Albert, A., Franchimont, P., & Lamy, M. (1997) · Critical Care Medicine · doi:10.1097/00003246-199703000-00006 · Cited by 252
Dysregulated interleukin 6 expression produces a syndrome resembling Castleman’s disease in mice
Brandt, S. J., Bodine, D. M., Dunbar, C. E., & Nienhuis, A. W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114749 · Cited by 248
Regulation of IL-6 in Immunity and Diseases
Tanaka, T., Narazaki, M., Masuda, K., & Kishimoto, T. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-024-0921-5_4 · Cited by 235
Host–pathogen interactions in bacterial meningitis.
Doran, K. S., Fulde, M., Gratz, N., Kim, B. J., Nau, R., Prasadarao, N., Schubert-Unkmeir, A., Tuomanen, E. I., & Valentin-Weigand, P. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1531-z · Cited by 208
Metadata
- Authors
- Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1989-01-01
- Volume
- 169
- Issue
- 1
- Pages
- 333-338
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2142585662
- Cited by
- 1,173
- References
- 15
- FWCI
- 71.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.